The amyloidogenicity of gelsolin is controlled by proteolysis and pH

Chemistry and Biology

Volumn 6, Issue 5, 1999, Pages 293-304

  Ratnaswamy, Gayathri ^a   Koepf, Edward ^a   Bekele, Haimanot ^a   Yin, Helen ^b   Kelly, Jeffery W ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Amyloid; Gelsolin; pH dependent; Proteolysis; Recombinant

Indexed keywords

EID: 0033133911     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(99)80075-1     Document Type: Article

References (73)

1. 1. Kwiatkowski, D.J., Stossel, T.P., Orkin, S.H., Mole, J.E., Colten, H.R. & Yin, H.L (1986). Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature 323, 455-458.
2. 2. Yin, H.L. (1987). Gelsolin: calcium-and polyphosphoinositide-regulated actin-modulating protein. BioEssays 7, 176-179.
3. 3. Janmey, P.A., Stossel, T.P. & Allen, P.G. (1998). Deconstructing gelsolin: identifying sites that mimic or alter binding to actin and phosphoinositides. Chem. Biol. 5, R81-R85.
4. 4. Lee, W.M. & Galbraith, R.M. (1992). The extracellular actin scavenger system and actin toxicity. N. Engl. J. Med. 326, 1335-1341.
5. 5. Kiurus, S. (1998). Gelsolin-related familial amyloidosis, finish type (FAF), and its variants found worldwide. Amyloid: Int. J. Exp. Clin. Invest. 5, 55-66.
6. 6. Lansbury, P.T. (1992). In pursuit of the molecular structure of the amyloid plaque: new technology provides unexpected and critical information. Biochemistry 31, 6865-6870.
7. 7. Blake, C. & Serpell, L. (1996). Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous ß-sheet helix. Structure 4, 989-998.
8. 8. Serpell, L.C., et al., & Blake, C.C.F. (1995). Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs. J. Mol. Biol. 254, 113-118.
9. 9. Kelly, J.W. (1996). Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol. 6, 11-17.
10. 10. Burtnick, L.D., Koepf, E.K., Grimes, J., Jones, E.Y., Stuart, D.I., Mclaughlin, P.J. & Robinson, R.C. (1997). The crystal structure of plasma gelsolin: implications for actin severing, capping, and nucleation. Cell 90, 661-670.
11. 11. Paunio, T., et al., & Peltonen, L. (1998). Cells of the neuronal lineage play a major role in the generation of amyloid precursor fragments in gelsolin-related amyloidosis. J. Biol. Chem. 273, 16319-16324.
12. 12. Maury, C.P.J., Nurmiaho-Lassila, E.-L. & Rossi, H. (1994). Amyloid fibril formation in gelsolin-derived amyloidosis: definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn187 and Tyr187 Gelsolin Peptides. Lab. Invest. 70, 558-564.
13. 13. Choo, D.W., Schneider, J.P., Graciani, N.R. & Kelly, J.W. (1996). Nucleated antiparallel ß-sheet that folds and undergoes self-assembly: a template promoted folding strategy toward controlled molecular architectures. Macromolecules 29, 355-366.
14. 14. Yamada, N., Ariga, K., Naito, M., Matsubara, K. & Koyama, E. (1998). Regulation of ß-sheet structures within amyloid-like ß-sheet assemblage from tripeptide derivatives. J. Am. Chem. Soc. 120, 12192-12199.
15. 15. Macias, M.J., et al., & Oschkinat, H. (1996). Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide. Nature 382, 646-649.
16. 16. Klunk, W.E., Pettegrew, J.W. & Abraham, D.J. (1989). Quanitative evaluation of congo red binding to amyloid-like proteins with a ß-pleated sheet conformation. J. Histochem. Cytochem. 37, 1273-1281.
17. 17. Fraser, P.E., Nguyen, J.T., Inouye, H., Surewicz, W.K., Selkoe, D.J., Podlisny, M.B. & Kirschner, D.A. (1992). Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid ß-protein. Biochemistry 31, 107160-10723.
18. 18. Valuer, B. & Weber, G. (1977). Resolution of the fluorescence excitation spectrum of indole into the 1La and 1Lb excitation bands. Photochem. Photobiol. 25, 441-444.
19. 19. Wüthrich, K. (1986). NMR of Proteins and Nucleic Acids. Wiley Interscience, New York.
20. 20. Goto, Y., Takahashi, N. & Fink, A.L. (1990). Mechanism of acid induced folding of proteins. Biochemistry 29, 3480-3488.
21. 21. Goto, Y., Calciano, L.J. & Fink, A.L. (1990). Acid-induced folding of proteins. Proc. Natl Acad. Sci. USA 87, 573-577.
22. 22. Fink, A.L., Calciano, L.J., Goto, Y., Kurotsu, T. & Palleros, D. (1994). Classification of acid denaturation of proteins: intermediates and unfolded states. Biochemistry 41, 12504-12511.
23. 23. Goto, Y. & Fink, A.L. (1989). Conformational studies of b-lactamase: Molten globule states at acidic and alkaline pH with high salt. Biochemistry 28, 945-952.
24. 24. Ghiso, J., Haltia, M., Prelli, F., Novello, J. & Frangione, B. (1990). Gelsolin variant (Asn187) in familial amyloidosis, Finnish type. Biochem. J. 272, 827-830.
25. 25. Levy, E., et al., & Frangione, B. (1990). Mutation in gelsolin gene in Finnish hereditary amyloidosis. J. Exp. Med. 172, 1865-1868.
26. 26. Haltia, M., et al., & Frangione, B. (1990). Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein. Biochem. Biophys. Res. Commun. 167, 927-932.
27. 27. Maury, C.P.J., Kere, J., Tolvanen, R. & De la Chapelle, A. (1990). Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett. 276, 75-77.
28. 28. Maury, C.P.J., Alli, K. & Baumann, M. (1990). Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsolin. FEBS Lett. 260, 85-87.
29. 29. Paunio, T., Kangas, H., Kalkkinen, N., Haltia, M., Palo, J. & Peltonen, L. (1994). Toward understanding the pathogenic mechanisms in gelsolin-related amyloidosis: in vitro expression reveals an abnormal gelsolin fragment. Hum. Mol. Genet. 3, 2223-2239.
30. 30. Kangas, H., Paunio, T., Kalkkinen, N., Jalanko, A. & Peltonen, L. (1996). In vitro expression analysis shows that the secretory form of gelsolin is the sole source of amyloid in gelsolin-related amyloidosis. Hum. Mol. Genet. 5, 1237-1243.
31. 31. Maury, C.P.J., Sletten, K., Totty, N., Kangas, H. & Liljestrom, M. (1997). Identification of the circulating amyloid precursor and other gelsolin metabolites in patients with G654A mutation in the gelsolin gene (Finnish familial amyloidosis): pathogenetic and diagnostic implications. Lab. Invest. 77, 299-304.
32. 32. Paunio, T., Kiuru, S., Karonen, S.-L., Palo, J. & Peltonen, L. (1994). Quantification of serum and cerebrospinal fluid gelsolin in familial amyloidosis, Finnish type (AGel). Amyloid 1, 80-89.
33. 33. Maury, C.P.J. & Rossi, H. (1993). Demonstration of a circulating 65K gelsolin variant specific for familial amyloidosis, Finnish type. Biochem. Biophys. Res. Commun. 191, 41-44.
34. 34. Sunada, Y., Sakurai, T., Nonomura, Y. & Kanazawa, I. (1994). Abnormal gelsolin fragments in the patients with familial amyloidosis of the Finnish type. In Amyloid Amyloidosis 1993: The Proceedings of the VII International Symposium on Amyloidosis, July 11-15, Kingston, Ontario, Canada. (Kisilevsky, R., Benson, M.D., Frangione, D., Gauldie, J., Muckle, T.J., & Young, I.D., eds.) pp 623-625, Parthenon Publications, New York.
35. 35. Colon, W. & Kelly, J.W. (1992). Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31, 8654-8660.
36. 36. Lai, Z., Colon, W. & Kelly, J.W. (1996). The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate which can self-assemble into amyloid. Biochemistry 35, 6470-6482.
37. 37. McCutchen, S., Colon, W. & Kelly, J.W. (1993). Transthyretin mutation Leu55→Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry 32, 12119-12127.
38. 38. McCutchen, S. L., Lai, Z., Miroy, G., Kelly, J.W. & Colon, W. (1995). Comparison of lethal and non-lethal transthyretin variants and their relationship to amyloid disease. Biochemistry 34, 13527-13536.
39. 39. Chan, S.L., Chronopoulos, S., Murray, J., Laird, D.W. & Ali-Khan, Z. (1997). Selective localization of murine ApoSAA1/SAA2 in endosomes-lysosomes in activated macrophages and their degradation products. Amyloid 4, 40-48.
40. 40. Charge, S.B.P., de Koning, E.J.P. & Clark, A. (1995). Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro. Biochemistry 34, 14588-14593.
41. 41. Fraser, P.E., Nguyen, J.T., Surewicz, W.K. & Kirschner, D.A. (1991). pH-Dependent structural transitions of Alzheimer amyloid peptides. Biophys. J. 60, 1190-1201.
42. 42. Guijarro, J.I., Sunde, M., Jones, J.A., Campbell, I.D. & Dobson, C.M. (1998). Amyloid fibril formation by an SH3 domain. Proc. Natl Acad. Sci. USA 95, 4224-4228.
43. 43. Wood, S.J., Wetzel, R. & Hurle, M.R. (1994). In Amyloid Amyloidosis 1993, The Proceedings of the VII International Symposium on Amyloidosis, July 11-15, Kingston, Ontario, Canada. (Kisilevsky, R., Benson, M.D., Frangione, D., Gauldie, J., Muckle, T.J., & Young, I.D., eds.) pp 523-525, Parthenon Publications. New York.
44. 44. Cataldo, A.M., Hamilton, D.J., Barnett, J.L., Paskevich, P.A. & Nixon, R.A. (1996). Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J. Neurosci. 16, 186-199.
45. 45. Chan, S.L., Chronopoulos, S., Murray, J., Laird, D.W. & Ali-Khan, Z. (1997). Selective localization of murine ApoSAA1/SAA2 in endosomes-lysosomes in activated macrophages and their degradation products. Amyloid 4, 40-48.
46. 46. De Koning, E.J.P., et al., & Clark, A. (1993). Localization of islet amyloid polypeptide (IAPP) in pancreatic islets of transgenic mice expressing the human or rat IAPP gene. Biochem. Soc. Trans. 21, 26s.
47. 47. Mayer, R.J., et al., & Landon, M. (1996). Endosome-lysosomes, ubiquitin and neurodegeneration. Adv. Exp. Med. Biol. 389, 261-269.
48. 48. Shirahama, T. & Cohen, A.S. (1975). Intralysosomal formation of amyloid fibrils. Am. J. Pathol. 81, 101-116.
49. 49. Shirahama, T., Miura, K., Ju, S.-T., Kisilevsky, R., Gruys, E. & Cohen, A.S. (1990). Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab. Inv. 62, 61-68.
50. 50. Harper, J.D., Wong, S.S., Lieber, C.M. & Lansbury, P.T., Jr. (1997). Observation of metastable Ab amyloid protofibrils by atomic force microscopy. Chem. Biol. 4, 119-125.
51. 51. Lambert, M.P., et al., & Krafft, G.A. (1998). Diffusable, nonfibrillar ligands derived from Ab1-42 are potent central nervous system toxins. Proc. Natl Acad. Sci. USA 95, 6448-6453.
52. 52. Jarrett, J. & Lansbury, P.T. (1993). Seeding one -dimensional crystallization of amyloid: a pathogenic mechanism in Alzheimer's disease and Scrapie? Cell 73, 1055-1058.
53. 53. Kelly, J.W. (1997). Amyloid fibril formation and protein misassembly: a structural quest for insights Into amyloid and prion diseases. Structure 5, 595-600.
54. 54. Kelly, J.W. (1998). The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8, 101-106.
55. 55. Miroy, G.J., Lai, Z., Lashuel, H., Peterson, S.A., Strang, C. & Kelly, J.W. (1996). Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc. Natl Acad. Sci. USA 93, 15051-15056.
56. 56. Peterson, S.A., Klabunde, T., Lashuel, H.A., Purkey, H., Sacchettini, J.C. & Kelly, J.W. (1998). Inhibiting transthyretin conformational changes that lead to amyloid fibril formation. Proc. Natl Acad. Sci. USA 95, 12956-12960.
57. 57. Lai, Z., McCulloch, J. & Kelly, J.W. (1997). GdnHCI-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers. Biochemistry 36, 10230-10239.
58. 58. Lee, S.-J., Liyanage, U., Bickel, P.E., Xia, W., Lansbury, P.T., Jr & Kosik, K.S. (1998). A detergent-insoluble membrane compartment contains A-ß in vivo. Nat. Med. 4, 730-734.
59. 59. Lansbury, P.T., Jr. (1997). Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's disease. Curr. Opin. Chem. Biol. 1, 260-267.
60. 60. Lansbury, P.T., Jr. (1997). Structural neurology: are seeds at the root of neuronal degeneration? Neuron 19, 1151-1154.
61. 61. Lansbury, P.T., Jr. (1996). A reductionist view of Alzheimer's disease. Accounts Chem. Res. 29, 317-321.
62. 62. Come, J.H., Fraser, P.E. & Lansbury, P.T., Jr. (1993). A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl Acad. Sci. USA 90, 5959-5963.
63. 63. Harper, J.D. & Lansbury, P.T., Jr. (1997). Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66, 385-407.
64. 64. Snyder, S.W., et al., & Holzman, T.F. (1994). Amyloid-ß aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67, 1216-1228.
65. 65. Golde, T.E., Estus, S., Younkin, L.H., Selkoe, D.J. & Younkin, S.G. (1992). Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255, 728-730.
66. 66. Shoji, M., et al., & Younkin, S.G. (1992). Production of the Alzheimer amyloid ß-protein by normal proteolytic processing. Science 258, 126-129.
67. 67. Selkoe, D.J. (1997). Alzheimer's disease: genotypes, phenotype and treatments. Science 275, 630-631.
68. 68. Selkoe, D.J. (1994). Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell. Biol. 10, 373-403.
69. 69. Schagger, H. & Von Jagow, G. (1987). Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368-379.
70. 70. Xie, Y., Lashuel, H., Miroy, G.J., Dikler, S. & Kelly, J.W. (1998). Recombinant human retinol-binding protein refolding, native disulfide formation and characterization. Protein Exp. Purif. 14, 31-37.
71. 71. Wetlaufer, D.B., Branca, P.A. & Chen, G.X. (1987). The oxidative folding of proteins by disulfide plus thiols does not correlate with redox potential. Protein Eng. 1, 141-146.
72. 72. Bigger, S.W., Craig, R.A., Ghiggino, K.P. & Schiers, J. (1993). Fluorescence anistropy measurements in undergraduate teaching. J. Chem. Edu. 70, A234-A239.
73. 73. Kraulis, P.J. (1991). Molscript: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950.